David Frederick James Leathers
Direttore/Membro del Consiglio presso Abingworth Management Holdings Ltd.
Provenienza dei contatti di primo grado di David Frederick James Leathers
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Abingworth Management Holdings Ltd.
Abingworth Management Holdings Ltd. Investment ManagersFinance Part of Abingworth LLP, Abingworth Management Holdings Ltd. is a British company that engages in the management of investment funds. The company is based in London, UK. Founded in 1989.
1
| Subsidiary | Investment Managers | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a David Frederick James Leathers tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Aurora Biosciences Corp.
Aurora Biosciences Corp. BiotechnologyHealth Technology Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA. | Biotechnology | Director/Board Member | |
GALAPAGOS NV | Biotechnology | Director/Board Member | |
Abingworth Management Ltd.
Abingworth Management Ltd. Investment ManagersFinance Abingworth Management Ltd. operates as an investment firm with interests in the life sciences and healthcare sectors. It offers services for businesses in all stages of company development, including early and late-stage venture financing, growth equity, and public companies. The company was founded in 1973 and is headquartered in London, the United Kingdom. | Investment Managers | Chairman | |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Private Equity Investor | |
N.M. Rothschild & Sons Ltd.
N.M. Rothschild & Sons Ltd. Major BanksFinance N.M. Rothschild & Sons Ltd. provides banking and financial services. It offers investment and commercial banking, treasury, merchant banking, fund management, private banking and trust management services to governments, corporations and individuals. The company has operations in USA, Zimbabwe, South Africa, Switzerland, United Arab Emirates, Sweden, Turkey, Singapore, Russia and Spain. N.M. Rothschild & Sons was founded in 1809 and is headquartered in London, the United Kingdom. | Major Banks | Corporate Officer/Principal | |
Genetic Therapy, Inc.
Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Genetic Therapy, Inc. develops human gene therapy products for the treatment of genetic and acquired diseases. The company also conducts research on human gene development. Genetic Therapy was founded by M. James Barrett in May 1986 and is headquartered in Gaithersburg, MD. | Miscellaneous Commercial Services | Director/Board Member | |
Hexagen Plc
Hexagen Plc BiotechnologyHealth Technology Part of Incyte Corp., Hexagen Plc develops technology for the discovery of single nucleotide polymorphisms. The British company was founded by Andrew Peter Sandham, Stephen William Bunting. Hexagen was acquired by Incyte Corp. on September 22, 1998 for $25.99 million. | Biotechnology | Founder | |
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
The University of Reading | College/University | Doctorate Degree | |
deVGen NV
deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Founder | |
ABLYNX | Biotechnology | Director/Board Member | |
Abingworth Bioventures V GP Ltd. | Director/Board Member | ||
Abingworth Bioventures IV GP Ltd. | Director/Board Member | ||
Abingworth Ventures (GP) Ltd. | Director/Board Member | ||
Abingworth Trustee Ltd. | Director/Board Member | ||
Elkinbrook Ltd. | Director/Board Member |
Statistiche
Distribuzione geografica
Regno Unito | 15 |
Stati Uniti | 4 |
Belgio | 4 |
Paesi Bassi | 2 |
Settori
Health Technology | 9 |
Finance | 5 |
Miscellaneous | 2 |
Electronic Technology | 2 |
Commercial Services | 2 |
Posizioni
Director/Board Member | 16 |
Chairman | 4 |
Founder | 3 |
Private Equity Investor | 1 |
Doctorate Degree | 1 |
Contatti più connessi
Insiders | |
---|---|
Stephen William Bunting | 22 |
- Borsa valori
- Insiders
- David Frederick James Leathers
- Connessioni Società